Market Overview

UPDATE: Jefferies Raises PT on Aetna Following Coventry Acquisition

Related AET
5 Companies That Allow People To Work From Home
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
WellPoint Profit Beats, ObamaCare Spurs Enrollment (Fox Business)

In a report published Thursday, Jefferies analyst David Windley reiterated a Buy rating on Aetna (NYSE: AET), and raised the price target from $69.00 to $74.00.

In the report, Jefferies noted, “We are raising our EPS projections to reflect the Coventry acquisition by 5-10c more than accretion guidance of $0.45-0.90 in 2014-15. The company's diversified business, strong execution, modest exposure to Exchange risk, and low-to-mid teens EPS growth make AET our favorite MCO. At 9.5x 2014E EPS, AET is second cheapest in the group with the most attractive risk/reward profile. Raising our PT to $74.”

Aetna closed on Wednesday at $60.29.

Latest Ratings for AET

DateFirmActionFromTo
Aug 2014Goldman SachsDowngradesBuyNeutral
Jul 2014BarclaysMaintainsOverweight
Jul 2014Deutsche BankMaintainsBuy

View More Analyst Ratings for AET
View the Latest Analyst Ratings

Posted-In: David Windley JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (AET)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters